 15 PM / Updated 6 minutes ago BRIEF-European Commission Approves Bristol-Myers Squibb's Yervoy Reuters Staff 1 Min Read 
Jan 22 (Reuters) - Bristol-Myers Squibb Co: 
* EUROPEAN COMMISSION APPROVES BRISTOL-MYERS SQUIBBâ€™S YERVOY (IPILIMUMAB) FOR TREATMENT OF PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH UNRESECTABLE OR METASTATIC MELANOMA 
* BRISTOL-MYERS SAYS EC EXPANDED INDICATION OF YERVOY TO INCLUDE TREATMENT OF ADVANCED MELANOMA IN PEDIATRIC PATIENTS 12 YRS OF AGE & OLDER Source text for Eikon: Further company coverage: